Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients

JOURNAL OF HEART AND LUNG TRANSPLANTATION

卷:32

Article

Kirklin, James K.¹  Naftel, David C.¹  Kormos, Robert L.²  Stevenson, Lynne W.³  Pagani, Francis D.⁴  Miller, Marissa A.⁵  Baldwin, J. Timothy⁵  Young, James B.⁶ 

[1] Univ Alabama Birmingham, Birmingham, AL 35294 USA

[2] Univ Pittsburgh, Presbyterian Univ Hosp, Med Ctr, Pittsburgh, PA USA

[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA

[4] Univ Michigan, Ann Arbor, MI 48109 USA

[5] NHLBI, Bethesda, MD 20892 USA

[6] Cleveland Clin Fdn, Lerner Coll Med, Cleveland, OH 44195 USA

关键词: mechanical support;    ventricular assist devices;    INTERMACS;    advanced heart failure;    destination therapy;   

DOI  :  10.1016/j.healun.2012.12.004

来源: Elsevier

【 摘 要 】

The 5th annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 6 years of patient and data collection. The current analysis includes more than 6000 patients and updated risk factors for continuous flow pumps. Among continuous flow pumps, actuarial survival is 80% at 1 year and 70% at 2 years. Quality of life indicators are generally favorable and adverse event burden will likely influence patient selections of advanced heart failure therapies. J Heart Lung Transplant 2013;32:141-156 (c) 2013 International Society for Heart and Lung Transplantation. All rights reserved.

【 授权许可】

Free